Ocular Therapeutix (OCUL) Shares Outstanding (Diluted) (2018 - 2026)
Ocular Therapeutix's Shares Outstanding (Diluted) was 224.95 million in Q2 2026, up 30.3% from 172.59 million a year earlier and up 0.4% from the prior quarter.
Powered by 
Analysis
Ocular Therapeutix (OCUL) Shares Outstanding (Diluted) (2018 - 2026) Analysis & Trends
For FY2025, Shares Outstanding (Diluted) at Ocular Therapeutix came in at 187.24 million, up 18.3% from FY2024.
- Shares Outstanding (Diluted) has now increased for seven consecutive years, with a five-year compound annual growth rate of 25.2% (FY2020 to FY2025).
- In earlier years, Shares Outstanding (Diluted) was 158.27 million in FY2024 (+84.9%), 85.6 million in FY2023 (+3.6%), 82.64 million in FY2022 (+0.6%) and 82.16 million in FY2021 (+35.2%).
- The Q2 2026 figure marks the highest quarterly Shares Outstanding (Diluted) in data going back to Q1 2018.
- Compared with a year earlier, Shares Outstanding (Diluted) has increased for 12 straight quarters, with growth averaging 38.1% over the last eight quarters.
- The best year-over-year quarter for Shares Outstanding (Diluted) over five years was Q2 2024 (growth of 112.5%); the worst was Q3 2022 (a decline of 9.9%).
- Per Business Quant data, OCUL's Shares Outstanding (Diluted) in the three quarters before Q2 2026 was 224.1 million (Q1 2026), 187.24 million (Q4 2025) and 183.92 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Ocular Therapeutix | 2.12 Bn | 2.12 Bn | 11.46 Mn | 224.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 224.95 Mn |
| Mar 31, 2026 | 224.10 Mn |
| Dec 31, 2025 | 187.24 Mn |
| Sep 30, 2025 | 183.92 Mn |
| Jun 30, 2025 | 172.59 Mn |
| Mar 31, 2025 | 169.40 Mn |
| Dec 31, 2024 | 158.27 Mn |
| Sep 30, 2024 | 166.99 Mn |
| Jun 30, 2024 | 165.82 Mn |
| Mar 31, 2024 | 132.02 Mn |
| Dec 31, 2023 | 85.60 Mn |
| Sep 30, 2023 | 85.14 Mn |
| Jun 30, 2023 | 78.05 Mn |
| Mar 31, 2023 | 77.39 Mn |
| Dec 31, 2022 | 82.64 Mn |
| Sep 30, 2022 | 76.98 Mn |
| Jun 30, 2022 | 82.53 Mn |
| Mar 31, 2022 | 82.51 Mn |
| Dec 31, 2021 | 82.16 Mn |
| Sep 30, 2021 | 85.45 Mn |
API Access
Ocular Therapeutix Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=OCUL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "OCUL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=OCUL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();